Tvardi Therapeutics (TVRD) Other Working Capital Changes (2018 - 2026)

Tvardi Therapeutics has reported Other Working Capital Changes for 9 years, with the latest figure at -$28000.0 in Q1 2026.

• Quarterly Other Working Capital Changes fell 16.67% year-over-year to -$28000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$107000.0 (down 48.61% YoY) and the FY2025 annual result came in at -$103000.0, down 10.75% from the prior year.
• Other Working Capital Changes held at -$28000.0 in Q1 2026 per TVRD's latest filing, from -$28000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $992000.0 in Q1 2025 and troughed at -$1.3 million in Q4 2025.
• A 3-year average of -$236428.6 and a median of -$382000.0 in 2026 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes soared 334.61% in 2023, then tumbled 102.3% in 2024.
• Over 5 years, Other Working Capital Changes stood at -$455000.0 in 2022, then surged by 329.45% to $1.0 million in 2023, then sank by 102.3% to -$24000.0 in 2024, then fell by 16.67% to -$28000.0 in 2025, then changed by 0.0% to -$28000.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$28000.0, -$28000.0, and -$26000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.